Nature Communications · 2019 · 52 citations · 48 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer MetabolismCancer ProgressionMetabolic ReprogrammingMetabolic Reprogramming In CancerMetastatic Breast CancerCancer Cell MigrationCancer Metastasis MechanismsCancer Signaling PathwaysMetabolic Signaling In MetastasisMetastatic Breast Cancer BiologyMetastatic MetabolismMetastatic SignalingStemness Signaling Pathways
The molecular mechanisms driving metastatic progression in triple-negative breast cancer (TNBC) patients are poorly understood. In this study, we demonstrate that epidermal growth factor-like 9 (EGFL9) is significantly upregulated in basal-like breast cancer cells and associated with metastatic progression in breast tumor samples. Functionally, EGFL9 is both necessary and sufficient to enhance cancer cell migration and invasion, as well as distant metastasis. Mechanistically, we demonstrate that EGFL9 binds cMET, activating cMET-mediated downstream signaling. EGFL9 and cMET co-localize at both the cell membrane and within the mitochondria. We further identify an interaction between EGFL9 and the cytochrome c oxidase (COX) assembly factor COA3. Consequently, EGFL9 regulates COX activity and modulates cell metabolism, promoting a Warburg-like metabolic phenotype. Finally, we show that combined pharmacological inhibition of cMET and glycolysis reverses EGFL9-driven stemness. Our results identify EGFL9 as a therapeutic target for combating metastatic progression in TNBC.
48
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve, Koei Chin, Jane Fridlyand et al. · Cancer Cell · 2006 · 3.2K citations · Full text
Medicine, Cell Biology, Oncology +14
Kari Fischer, Anna Durrans, Sharrell Lee et al. · Nature · 2015 · 1.8K citations
Medicine, Cell Biology, Oncology +14
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne‐Pierre Morel, Marjory Lièvre, Clémence Thomas et al. · PLoS ONE · 2008 · 1.6K citations · Full text
Medicine, Cancer Biology, Oncology +17